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Androgen Receptor and the Testes Influence
Hypertension in a Hybrid Rat Model
Daniel L. Ely, Ron Salisbury, Disha Hadi, Monte Turner, and Mark L. Johnson
The objective of this study was to determine if males with a deficient androgen receptor would
develop hypertension when crossed with a hypertensive parent Female King-Holtzman rats
(n=15), heterozygous for the testicular feminization (Tfm) gene, were crossed with male
spontaneously hypertensive rats (SHR), and blood pressure was measured weekly from 5-14
weeks in the F, hybrid males. Approximately 50% of the F, hybrid males were Tfm males and
androgen receptor-deficient, and 50% were normal. Blood pressure in the parent King-
Holtzman males, Tfms, and female rats was also followed for the same time period. The F,
normal male hybrids had a significantly higher (p<0.05) systolic blood pressure than the Tfm
hybrid males after 12 weeks (195±8 versus 170±8 mm Hg, respectively). Blood pressure in the
male and Tfm Holtzman rats was 120±5 mm Hg and 110±6 mm Hg, respectively. Castration
lowered blood pressure by 38 mm Hg in the hybrid males and 27 mm Hg in the Tfm hybrids.
Female F, hybrids also showed a pressure rise above that of female Holtzman controls (155±6
mm Hg versus 110±6 mm Hg, /><0.01) but lower than the F, males and Tfm hybrids.
Ovariectomized females with testosterone implants did not show an elevation in blood pressure.
Plasma electrolytes, norepinephrine, and cholesterol were not significantly different between
normal and Tfm hybrid males. The results suggest that the presence of an androgen receptor
and a testis-derived factor mediate the blood pressure rise in the hybrid males. A Y
chromosome effect or sex-influenced locus may be involved since both the normal and Tfm
males had significantly higher blood pressures than their female siblings. (Hypertension
Sex differences in systolic and diastolic bloodpressure by age have been reported in moststudies of developed societies. The US Public
Health Service National Health Survey,1 The Tecum-
seh Study,2 and similar epidemiological longitudinal
studies in Norway,3 Poland,4 and Japan5 have re-
ported that men have higher blood pressure than
women at younger ages (second through third de-
cade) with a crossover in women to higher pressures
in the fourth to sixth decade. The crossover phenom-
enon appears to be characteristic of nearly all devel-
oped societies and is seen most clearly with systolic
pressure. Similar conclusions are reached whether
the results are expressed as the mean pressure by age
and sex or as prevalence of hypertension. There are
only a few blood pressure studies in children, but
available data suggest that there are no significant sex
differences.6 These studies and experimental studies
suggest that the male sex hormones, specifically
testosterone, play a role in the sexual differentiation
of hypertension.7-14
From the Department of Biology, The University of Akron,
Akron, Ohio.
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Recently, our laboratory has shown that the Y
chromosome is involved in the development of hy-
pertension in the SHR model.11 As an extension of
this research, we have asked the question whether
testosterone and the androgen receptor may influ-
ence the development of hypertension, and to test
this hypothesis, we developed a hybrid animal model
having the potential for genes that could produce
hypertension and genes that could produce deficient
androgen receptors. The animals that are deficient in
androgen receptors are referred to as testicular fem-
inized males (Tfm), and they show the developmen-
tal effects of androgen deficiency. The Tfm male is a
genotypic XY male, but the phenotype of the adult is
female and internally there is an undescended testis
that secretes testosterone.
The Tfm trait has been studied in rats, mice, and
humans and is believed to be transmitted to offspring
via the X chromosome.15-19 Half of the male offspring
of a cross of females heterozygous for the trait with
normal breeding males are Tfm and the other half
are normal; half of the female offspring are carriers
and the other half are noncarriers of the trait.
Methods
The parental SHR strain was obtained from Harlan
Sprague Dawley, Indianapolis, Ind., which obtained
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the initial breeding stock from the National Institutes
of Health (NIH). According to the most current
Harlan Sprague Dawley genetic monitoring report,
this strain is comparable with most genetically authen-
tic hypertensive strains in the United States that were
derived from the NIH colonies (personal communica-
tion, Harlan Sprague Dawley, 1988). The parental
strain of King-Holtzman Tfm rats was obtained as a
generous gift from Dr. Richard Krieg Jr. at the
Medical College of Virginia. Their colony, in turn, was
derived from a colony at the University of Oklahoma
and is often referred to as the Stanley-Grumbach
strain (the strain having been named for its develop-
ers).
Experiment 1
Females carrying the Tfm gene were bred to
spontaneously hypertensive rat (SHR) males. Nor-
mal male and female and Tfm male offspring were
obtained and their blood pressure was measured
from 5 to 14 weeks of age. A typical breeding box
(40x50x20 cm) consisted of three females and one
male housed in aspen shavings (changed once per
week, American Excelsior, Cleveland, Ohio) and
provided with water and Purina lab chow ad libitum.
Ten such breeding cages were established (n=30
females, 10 males). Room temperature (26°-28°C)
and humidity (40-50%) were maintained at slightly
higher than usual levels to minimize respiratory
infections. The 12-hour light/dark cycle (6:00 AM-
6:00 PM, light; 6:00 PM-6:00 AM, dark) was kept
constant. Litters were weaned and grouped by sex at
3 weeks of age and maintained by sibling group and
sex for the duration of the experiments. Both normal
male and Tfm-matched siblings were kept in the
same cage and ear tagged with metal number clips.
The following groups of rats were used (n=8-12/
group): normal hybrid males, hybrid Tfm, and hybrid
females. In addition, blood pressure was measured in
the normal females and males of the parent strain:
normal King-Holtzman males (n = 12), Tfm rats
(n=10), King-Holtzman females {n=\2), SHR males
(n = 10), and SHR females (n = 12). Blood pressures
were measured weekly between 5 and 14 weeks of
age in King-Holtzman hybrid groups and between 5
and 20 weeks in SHR by tail sphygmomanometry
(International Biomedical, Inc., Austin, Tex.).20 Each
cage of rats was placed one at a time for 30 minutes
in a preheated warming chamber (39°C), and each
rat put into a plastic restraint before having five
blood pressures taken, which took 2-3 minutes. This
technique was performed on conscious animals and,
due to the overall chamber warming, the animals
were lethargic and vasodilated and did not struggle
during the procedure. Weekly pressures and body
weights were measured by the same technician with-
out knowledge of experimental group or objective.
Trunk blood was collected on termination for analy-
sis of testosterone, norepinephrine, cholesterol, and
electrolytes. Plasma testosterone was determined by
radioimmunoassay (Radioassays Systems Labora-
tory, Carson, Calif.), catecholamines by high-perfor-
mance liquid chromatography with electrochemical
detection,21 and electrolytes and cholesterol by an
automated colorimetric procedure (Technicon,
Southgate Medical Lab, Cleveland, Ohio).
The following organs were removed and weighed
on termination: pituitary, adrenal glands, testes, and
heart ventricles. Weights were recorded as relative
weight per 100 grams body weight.
Experiment 2
The objective of experiment 2 was to determine
the effects of prepubertal castration on blood pres-
sure in both the normal hybrid males and the hybrid
Tfm animals. At 5 weeks of age, castrations were
performed on normal males («=10) and Tfm rats
(n = 10) under sodium brevital anesthesia (50 mg/kg
i.p., Eli Lilly and Co., Indianapolis, Ind.) using an
abdominal incision. Ethicon suture (5-0) (Ethicon
Inc., Somerville, N.J.) was used to close the wounds,
and 5,000 units of penicillin G were given intramus-
cularly. The rats were allowed 1 week of recovery
before blood pressures were measured as in experi-
ment 1. Trunk blood was collected at termination for
plasma testosterone as in experiment 1.
Experiment 3
The objective of experiment 3 was to determine
the effects of ovariectomy and testosterone adminis-
tration on blood pressure in the hybrid females.
Three groups of females (5 weeks of age) were used:
controls with intact ovaries (n = 12), ovariectomized
females with testosterone implants (n=6), and ovari-
ectomized females with sham implants (n=6). Test-
osterone implants were made from Silastic tubing
(Dow Corning, Midland, Mich.) having a packing
length of 19 mm (i.d. 0.062 mm, o.d. 0.125 mm). After
packing with testosterone proprionate (10 mg) (Ster-
aloids Inc.) the ends were sealed with Silastic medical
grade silicone adhesive (Type A, Dow Corning). The
implants were cured overnight and soaked in 70%
ethanol for 2 hours before implanting them. The
sham tube was empty. The tubes were placed in the
neck region subcutaneously and were replaced with
new implants every 3 weeks under ether anesthesia.
The ovariectomy was performed under sodium brevi-
tal anesthesia (50 mg/kg i.p.), and Ethicon suture
(5-0) was used to close the wound. Rats were given
5,000 units of penicillin G and were allowed to
recover for 1 week before blood pressures were taken
as in experiment 1. On termination, trunk blood was
collected for testosterone measurement as in exper-
iment 1.
Statistical analysis was performed by two-way analy-
sis of variance (ANOVA), Scheffe's test, and Stu-
dent's t tests (one-tailed). The animals were main-
tained in a humane way according to NIH guidelines.
Results
A female Tfm gene carrier having a slightly gray-
colored coat was crossed with a pure white male
SHR.
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FIGURE 1. Line graph showing systolic blood pressure of
normotensive King-Holtzman males, King-Holtzman females,
and King-Holtzman testicular feminized male (Tfm) rats
between 5 and 14 weeks of age (mean±SEM).
The Fi offspring (100%) of such a cross had a black
dorsal coat.
The blood pressure results for experiment 1 will be
presented by first showing the blood pressures of
each parental strain and then the pressures of the F!
hybrid strains.
There were significant differences (two-way
ANOVA, group effect: F=9.5, p<0.001; age effect:
F=2A,p<0.05; interaction: F=1.7,p<0.05) in blood
pressure over time between the King-Holtzman
males, King-Holtzman Tfm animals, and King-Holtz-
man females (Figure 1). Overall, the pressures of
these groups were in the normotensive range, al-
though the normal androgen receptor males showed
a slight unexplained significant elevation between 12
and 14 weeks as compared with females and Tfm rats
(p<0.01, t test). This rise was also seen in male SHR
and hybrids between 11 and 14 weeks. Also, the Tfm
rats had slightly higher pressures than the females or
normal King-Holtzman males at 5 weeks (p<0.05, t
test). Figure 2 shows the typical marked elevation of
blood pressure in SHR males at 14-20 weeks when
compared with females (230 versus 160 mm Hg,
respectively, /?<0.001). Blood pressure in the F[
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FIGURE 2. Line graph showing systolic blood pressure of
spontaneously hypertensive male and female rats (SHR) be-
tween 8 and 20 weeks of age, *p<0.05, **+p<0.001, t tests,
mean±SEM.
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FIGURE 3. Line graph showing systolic blood pressure of F,
hybrids (testicularfeminized male [Tfm] carrierfemalexSHR
male). Normal androgen receptor males, Tfm-androgen-defi-
cient males, and females between 5 and 12 weeks of age are
compared. *p < 0.05, **p<0.01 compared with normal andro-
gen receptor males, t test, mean±SEM).
hybrid rats is illustrated in Figure 3. The normal
males exhibited a rapid rise in blood pressure after 12
weeks into the hypertensive range (195 mm Hg)
when compared with the significantly lower pressure
of their hybrid Tfm (170 mm Hg;/><0.05, t test) and
female (155 mm Hg;p<0.05, t test) siblings (two-way
ANOVA, group effect: F=21.5,p<0.001; age effect:
F=30.9, p<0.001; interaction: F=3.8,p<0.001). The
female hybrids had significantly lower blood pressure
than the normal hybrid males (/?<0.05, t test) at 11
and 12 weeks, but there were no significant differ-
ences compared with hybrid Tfm rats (t test). The
effects of castration on blood pressure (experiment 2)
are seen in Figure 4. Castration significantly (/ tests)
lowered blood pressure by 38 mm Hg (/?<0.01) in the
hybrid males and by 27 mm Hg (/?<0.01) in the Tfm
hybrids. The blood pressure difference between the
hybrid Tfm and its normal androgen receptor sibling
male remained significant after castration. Plasma
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FIGURE 4. Line graph showing systolic blood pressure of
castrated (Cast.) normal androgen receptor male hybrids and
castrated testicular feminized male (Tfm) hybrids (Tfm earner
female Xspontaneously hypertensive rat male) as compared
with their respective counterpart group with intact testes
(mean±SEM). **p<0.01, castrated group compared with
respective intact group, t test.
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FIGURE 5. Line graph showing systolic blood pressure of
female hybrids (testicular feminized male [Tfm] carrier
female Y. spontaneously hypertensive rat male) who have an
intact ovary compared with those who were ovariectomized
(Ovx) and given testosterone implants or Ovx and given a
placebo (mean±SEM). There were no significant differences
between groups (two-way analysis of variance)
testosterone was below the limits of detectability in
both castrate groups.
The effects of ovariectomy on blood pressure (ex-
periment 3) can be seen in Figure 5. The majority of
pressures over time for all three groups were in the
normotensive range, and testosterone administration
did not increase blood pressure although at week 10
there was a nonsignificant rise to 158 mm Hg. Plasma
testosterone was 0.5 ±0.5 ng/ml both in the intact
and ovariectomized females and was 1.9 ±0.4 /ig/ml
in the implant group.
The organ weight comparisons of experiment 1 are
seen in Table 1. The Tfm hybrids had significantly
larger pituitary glands (161% of normal males,
p<0.01) and adrenal glands (200% of normal males,
p<0.05), but smaller testes (33% of normal males,
/?<0.001) when compared with matched normal sib-
ling males. The heart ventricular weights among the
three groups did not differ significantly.
The blood chemistries for experiment 1 are re-
ported in Table 2 and show the respective testoster-
one, norepinephrine, electrolyte, and lipid levels. As
expected, the hybrid Tfm animals had higher tes-
tosterone levels than the normal hybrid males, which
were higher than females, and castrated males were
below the limits of detectability. There were no
significant differences between male groups in nor-
epinephrine, cholesterol, or electrolytes. The hybrid
females had lower testosterone (p<0.05) and higher
norepinephrine (p<0.05) than normal males.
Discussion
In our previous work, we showed that the blood
pressure rise in F! offspring resulting from a cross of
a Wistar-Kyoto (WKY) female with an SHR male
required both a Y chromosome component and an
autosomal component. The present results support a
role for the Y chromosome in transmitting hyperten-
sion genes in the SHR rat.11 The blood pressure
observed in the male hybrids (195 mm Hg) was
comparable with that of the parent SHR males at 12
weeks of age (190 mm Hg). Since the males of the
normotensive Holtzman strain normally have a blood
pressure of 155 mm Hg at 12 weeks of age, this
suggests that the increase of 40 mm Hg in the hybrid
males was due to genes inherited from the SHR
fathers. The results further suggest that about 15-20
mm Hg of this 40 mm Hg was due to an androgen
receptor effect. The evidence for this is derived from
an analysis of the Tfm data. The Holtzman Tfm rat
had pressures that were 15 mm Hg lower than the
normal Holtzman males at 12 weeks of age (140
versus 155 mm Hg), and the hybrid Tfm animals had
pressures that were 25 mm Hg lower than the normal
hybrid males at 12 weeks (170 versus 195 mm Hg).
The remainder (15 mm Hg) of the 40 mm Hg
pressure difference must be accounted for by either
non-androgen receptor-mediated effects or by other
gene effects. Support for this conclusion can be seen
TABLE
Group
Hybrid
Hybrid
Hybrid
TABLE 1. Relative Organ Weights of Hybrid Groups
Group
Hybrid normal males
Hybrid testicular
feminized males
Hybrid females
Pituitary
2.72±0.23
4.53±0.1*
4 64±0.36*
Values are mean±SEM. NA, not applicable
•p<0.01, tp<0.001, $p<0 05 compared with hybrid
(mg/100 g body wt)
Adrenal
glands
17.6±0.9
34.9±1 3t
22.9±0 9*
normal males.
2. Blood Chemistry of Hybrid Normal Males, Hybrid TesrJcnlar Feminized Males, and
normal males (n=8)
testicular feminized males (n=9)
females (n = 12)
Testosterone
(ng/ml)
2.1±0.35
4.0±0.5*
0 5 ±0.5
Norepinephrine
(pg/ml)
429 ±50
383 ±45
601 ±135*
Testes
710±3O
235±9t
NA
1 Hybrid Females
Cholesterol Na+
(mg/dl) (meq/1)
60±2.1
69 ±2.5
61±3
146±2
144±2
145 ±2
Heart
ventricles
331±23
311±4
339±10
K+
(meq/1)
6.4±2.8
5.6±1.3
6 0±21
cr
(meq/l)
107±1.2
106±0 8
108±0.7
Values are mean±SEM.
*p<0.05 compared with normal males.
 by guest on March 25, 2014http://hyper.ahajournals.org/Downloaded from 
1108 Hypertension Vol 17, No 6, Part 2 June 1991
in the blood pressure differences between the F!
hybrid females and the parent Holtzman females.
The blood pressure difference between these two
strains was also 20 mm Hg (155 versus 135 mm Hg,
respectively).
The castration experiments demonstrated that
blood pressure could be normalized in the hybrid
males from 195 down to 155 mm Hg or about a 40
mm Hg testis-dependent effect. This finding supports
the conclusion that the testes are necessary for the
blood pressure rise and, combined with the previous
observation, suggests that some of the effects of the
testes may be due to the action of androgens through
non-androgen receptor processes or to some other
testis-derived factor. In support of the latter sugges-
tion, blood pressure in the castrated hybrid Tfm rats
was lower (23 mm Hg) than that of the gonadally
intact hybrid Tfm rats (147 versus 170 mm Hg,
respectively) (i.e., even though there were deficient
androgen receptors in both Tfm groups, castration
lowered the blood pressure). This effect is testis-
specific because it did not occur in females that were
ovariectomized. Therefore, the mechanism for this
decrease may be through another testis-derived fac-
tor or through a non-androgen receptor-mediated
effect of androgens. A precedent for non-androgen
receptor-mediated androgen effects exists. Leiter22
has shown, in studying the genetics of diabetes sus-
ceptibility in mice, that the liver may be androgenized
even without functional androgen receptors. In addi-
tion, functional androgen receptors were not re-
quired to mediate the diabetes promotive action of
androgens in genetically obese mice.22
One possible testis-derived factor would be estro-
gen. Testosterone is readily converted to estrogen in
the peripheral tissues of both the Tfm and its normal
male sibling. In the Tfm, blood estradiol levels are
elevated above that of the normal male.23 However,
how estrogen may act on blood pressure in the male
in a manner different from that in a female is not yet
known.
Also, it is possible that in the hybrid Tfm rats, less
deoxycorticosterone is produced than in the hybrid
normal males or in SHR, which could reduce the
blood pressure. In DahJ salt-sensitive rats, the effects
of the Hyp-1 locus caused a twofold to threefold
higher plasma level of 180H-deoxycorticosterone
(DOC) than in resistant rats, but the plasma levels of
corticosterone and DOC were not different between
the strains.24-25
Also supportive of this possibility is the fact that
the pituitary and adrenal weights of the hybrid Tfm
rats were significantly elevated compared with the
hybrid male controls, suggesting reduced DOC feed-
back to these tissues and consequent hypertrophy.
There appears to be a developmental effect on
blood pressure that occurs around 10-12 weeks of
age. At this time the blood pressure is significantly
increased in the hybrid males and in the normal
King-Holtzman males and only slightly later at 12-13
weeks in the male SHR. However, this elevation did
not occur in females or in the hybrid Tfm rats or in
castrated hybrid males. This again underscores the
importance of the testes in the pressure rise at this
time. For testosterone to influence target organs
involved in blood pressure control, nuclear binding
needs to be demonstrated. Indeed, Stumpf26 has
shown that dihydrotestosterone binds to blood vessel
wall, heart, and central nervous system cardiovascu-
lar areas, and castration of SHR males before pu-
berty has been shown to normalize their pressures.13
Castration also abolished the blood pressure sexual
differences in DOC-salt hypertension in Sprague-
Dawley rats.12 Also Cambotti et al13 reported that the
neonatal gonadal hormone milieu contributed signif-
icantly to the sexually differentiated pattern of hyper-
tension in the SHR.
Also, Ganten et al8 have shown that prepubertal
administration of androgen receptor blockers in SHR
males significantly reduced blood pressure in the
adults. However, the same treatments had no effect
in old hypertensive rats.8
A potential testosterone effect on blood pressure
may be through enhanced sympathetic outflow, which
can increase blood pressure. Lara et al27 showed that
testosterone modulated norepinephrine storage and
release in the sympathetic fibers of the rat vas defer-
ens. Also, there was enhancement of norepinephrine
pressor responses in testosterone-treated cats,28 and
Salt29 showed in testosterone blocker studies (high
levels of circulating testosterone) that the norepineph-
rine uptake-2 mechanism was reduced, thereby in-
creasing plasma norepinephrine, which could influ-
ence blood pressure. In addition, androgens may
enhance the pressor action of norepinephrine.28 In
our present studies, the resting plasma norepineph-
rine levels were not different between male groups,
but this does not rule out the possibility of regional
differences of sympathetic output and regional norepi-
nephrine differences that could affect blood pres-
sure.30 This interactive influence could be similar to
the potentiation of norepinephrine by salt as reported
in our animal studies.31-32
Also, there may be an interaction between cardio-
vascular target organs, testosterone, and blood pres-
sure. Lengsfeld et al33 have reported that gonadectomy
and hormonal replacement changes systolic blood pres-
sure and ventricular myosin isoenzyme pattern in SHR
stroke-prone rats. They showed that ventricular myosin
isoenzyme pattern was under the dominant control of
androgens and dissociates the expression of myosin
isoenzyme from both blood pressure and cardiac hy-
pertrophy. However, preliminary studies in our labora-
tory have found no functional differences in isolated
left ventricular performance between hybrid Tfm or
hybrid normal rats (unpublished observations). This is
not to say that testosterone does not produce significant
biochemical changes in the heart; indeed, the enzyme
changes reported are important in cardiac hypertrophy
and heart development. Also, testosterone may alter
the ratio of elastin to collagen in resistance vessels,
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which could increase resistance and elevate blood
pressure.34
With regard to the effects of testosterone on
female blood pressure, a question arises. If testoster-
one is developmentally involved in hypertension,
then why didn't the females exhibit a pressure rise
after ovariectomy and testosterone administration?
One explanation could be that the testosterone needs
to be present at a critical time before 5 weeks of age.
Another possible explanation is that a Y chromo-
some, which a female lacks, is necessary for the full
expression of the developmental effect. For instance,
if there is a gene on the Y chromosome that influ-
ences steroid metabolism, then just the presence of
male levels of testosterone may not be sufficient to
cause the blood pressure elevation seen in males. An
enzyme regulating the metabolism of testosterone
such as steroid sulfatase (STS) may be involved. The
gene for STS has been reported both on the X and
the Y chromosome in the mouse, but its location in
the rat is not known.22 If the gene is expressed from
both the X and the Y chromosomes in males, then it
is possible that higher levels of STS would permit
more free androgens to androgenize critical tissues,
inducing morphological changes that increase blood
pressure. Also, our data does not suggest an estrogen
protective effect on blood pressure since the ovariec-
tomy group with placebo did not show a blood
pressure rise.
In conclusion, blood pressure was lowered in male
hybrids with deficient androgen receptors. This could
be due to both organizational effects in the central
nervous system and peripheral organs during devel-
opment or due to decreased activational effects in the
adult peripheral target organs. Since castration be-
fore puberty produced a greater drop in blood pres-
sure than androgen deficiency alone, we conclude
that there may be non-receptor-mediated effects of
androgens or a testis-derived factor influencing blood
pressure. Since blood pressure remained higher in
hybrid castrated rats having a normal population of
androgen receptors compared with hybrid castrated
Tfm rats, we suggest that the androgens have a
developmental effect on blood pressure before pu-
berty. Finally, androgens may interact synergistically
with the autosomes and the Y chromosome to elevate
blood pressure in the male.
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